These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17119052)

  • 21. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
    Dogan I; Onen HI; Yurdakul AS; Konac E; Ozturk C; Varol A; Ekmekci A
    Med Sci Monit; 2009 Aug; 15(8):BR232-42. PubMed ID: 19644412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AKT1 polymorphisms and survival of early stage non-small cell lung cancer.
    Kim MJ; Kang HG; Lee SY; Jeon HS; Lee WK; Park JY; Lee EB; Lee JH; Cha SI; Kim DS; Kim CH; Kam S; Jung TH; Park JY
    J Surg Oncol; 2012 Feb; 105(2):167-74. PubMed ID: 21842521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
    Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
    Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
    Dediu M; Crisan E; Radut M; Tarlea A; Median D; Alexandru A; Vremes G; Gal C
    Lung Cancer; 2009 Feb; 63(2):271-6. PubMed ID: 18565617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation.
    Bogunia-Kubik K; Middleton P; Norden J; Dickinson A; Lange A
    Int J Immunogenet; 2008 Jun; 35(3):207-13. PubMed ID: 18312595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.
    Saintigny P; Besse B; Callard P; Vergnaud AC; Czernichow S; Colombat M; Girard P; Validire P; Breau JL; Bernaudin JF; Soria JC
    Clin Cancer Res; 2007 Aug; 13(16):4825-31. PubMed ID: 17699861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
    Xu Y; Shibata A; McNeal JE; Stamey TA; Feldman D; Peehl DM
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):23-7. PubMed ID: 12540499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer.
    Gu J; Berman D; Lu C; Wistuba II; Roth JA; Frazier M; Spitz MR; Wu X
    Clin Cancer Res; 2006 Dec; 12(24):7329-38. PubMed ID: 17189404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D receptor gene polymorphisms and breast cancer risk.
    Guy M; Lowe LC; Bretherton-Watt D; Mansi JL; Peckitt C; Bliss J; Wilson RG; Thomas V; Colston KW
    Clin Cancer Res; 2004 Aug; 10(16):5472-81. PubMed ID: 15328186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
    Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapy.
    Yoon SM; Hong YC; Park HJ; Lee JE; Kim SY; Kim JH; Lee SW; Park SY; Lee JS; Choi EK
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):885-91. PubMed ID: 16199318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
    Zell JA; Ou SH; Ziogas A; Anton-Culver H
    Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
    Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
    Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapy.
    Masago K; Togashi Y; Fujita S; Nagai H; Sakamori Y; Okuda C; Kim YH; Mishima M
    Oncology; 2013; 84(4):214-8. PubMed ID: 23364242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
    Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
    Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
    Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort.
    Jatoi A; Williams B; Nichols F; Marks R; Aubry MC; Wampfler J; Finke EE; Yang P
    Lung Cancer; 2005 Jul; 49(1):77-84. PubMed ID: 15949593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.
    Ma H; Shu Y; Pan S; Chen J; Dai J; Jin G; Hu Z; Shen H
    Lung Cancer; 2011 Nov; 74(2):164-9. PubMed ID: 21514686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.